Investor Summary

At O’VISTA, we’ve built a scientifically grounded, AI-powered platform to transform how dyslexia is detected and supported—addressing a global learning challenge affecting up to 20% of children, yet often missed until it’s too late for optimal intervention.

Our approach is rooted in peer-reviewed oculomotor research: we objectively measure subtle eye-movement anomalies—such as erratic fixations, prolonged regressions, and impaired binocular coordination—during reading tasks. These biomarkers are quantifiable, replicable, and detectable years before academic failure becomes evident, eliminating reliance on subjective teacher referrals or costly psychoeducational batteries.

Unlike fragmented screening tools, O’VISTA integrates diagnosis and therapy into a single, scalable system:

• Non-invasive, 5-minute assessment via proprietary eye-tracking hardware
• Real-time AI analytics that generate personalized cognitive profiles
• Immersive, gamified therapy via a 50-inch touchscreen linked to a balance board—enhancing sensorimotor integration, focus, and reading fluency
• Multimodal scaffolding (text-to-speech, gaze-guided pacing, adaptive highlighting) co-designed with neurodiverse children

This end-to-end model is already live through our transmedia initiative, The Magical Codex of Central Deborah (magical-codex.com), which embeds therapeutic reading into emotionally engaging storytelling—blending neuroscience, narrative, and inclusive design.

We are strategically launching first in the Gulf Cooperation Council (GCC) and broader Middle East region, where:

• Regulatory pathways for educational and health-tech innovation are streamlined
• Strong government investment in edtech, special needs education, and national cognitive development agendas
• High unmet demand for objective, scalable learning-difficulty screening in both public and private schools

Success here will generate clinical validation, revenue, and operational proof points—de-risking expansion into Europe, Canada, the U.S., and Australia, where dyslexia support is well-funded but fragmented, and where our GDPR/HIPAA-ready architecture ensures rapid compliance.

With dyslexia costing educational systems billions annually in remediation and lost potential, O’VISTA offers more than a tool—it offers a preventive, scalable, and human-centered solution. We invite investors to join us in building the global standard for early learning-difficulty support—starting in the Gulf, scaling worldwide.